MONUMENT SERIES FUND INC
NSAR-B, EX-27, 2001-01-02
Previous: MONUMENT SERIES FUND INC, NSAR-B, EX-27, 2001-01-02
Next: MONUMENT SERIES FUND INC, NSAR-B, EX-27, 2001-01-02



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0001037813
<NAME> MONUMENT SERIES FUND, INC.
<SERIES>
   <NUMBER> 023
   <NAME> Monument Medical Science - CLASS C

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                     $ 39,131,523
<INVESTMENTS-AT-VALUE>                    $ 44,115,249
<RECEIVABLES>                             $    202,144
<ASSETS-OTHER>                            $    196,644
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                            $ 44,514,037
<PAYABLE-FOR-SECURITIES>                  $    617,050
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                      717,168
<TOTAL-LIABILITIES>                          1,334,218
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                    38,731,250
<SHARES-COMMON-STOCK>                            1,513
<SHARES-COMMON-PRIOR>                                0
<ACCUMULATED-NII-CURRENT>                            0
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                      (488,898)
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                     4,937,467
<NET-ASSETS>                                43,179,819
<DIVIDEND-INCOME>                               40,499
<INTEREST-INCOME>                              321,490
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                 714,407
<NET-INVESTMENT-INCOME>                      (352,418)
<REALIZED-GAINS-CURRENT>                     (486,110)
<APPREC-INCREASE-CURRENT>                    4,838,272
<NET-CHANGE-FROM-OPS>                        3,999,744
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                          583
<DISTRIBUTIONS-OF-GAINS>                        68,831
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                         48,765
<NUMBER-OF-SHARES-REDEEMED>                      2,845
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                      41,754,286
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                          348,176
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                909,726
<AVERAGE-NET-ASSETS>                                 0
<PER-SHARE-NAV-BEGIN>                            30.05
<PER-SHARE-NII>                                  (.23)
<PER-SHARE-GAIN-APPREC>                           1.29
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                              3.53
<PER-SHARE-NAV-END>                              31.11
<EXPENSE-RATIO>                                   3.00



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission